Brunner M, Grützmann R (2024)
Publication Type: Journal article
Publication year: 2024
DOI: 10.1007/s00104-024-02143-5
Pancreatic cystic lesions represent a challenging heterogeneous entity with a potential risk of malignant transformation. The diagnostics include in particular medical history taking with collection of relevant clinical information and high-resolution imaging, preferably using magnetic resonance imaging (MRI) with MR cholangiopancreatography (MRCP) and/or endoscopic ultrasonography. A differentiation between different cystic entities and identification of risk factors are crucial for making appropriate treatment decisions. Only a small proportion of pancreatic cystic neoplasms require surgery. Pancreatic cystic lesions with a relevant risk of malignancy, such as main duct intraductal papillary mucinous neoplasms (IPMN), mucinous cystic neoplasms (MCN), solid pseudopapillary neoplasms (SPN) and general cystic pancreatic lesions with risk factors regardless of the entity, should be resected, whereas an individualized approach is required for branch duct IPMN and serous cystic neoplasms (SCN) and dysontogenetic cysts require no treatment. Parenchyma-sparing and minimally invasive resection techniques should be preferred whenever possible for resecting pancreatic cystic tumors. Approximately 10% of patients develop recurrences over time.
APA:
Brunner, M., & Grützmann, R. (2024). Pancreatic cystic neoplasms Zystische Pankreastumoren. Die Chirurgie. https://doi.org/10.1007/s00104-024-02143-5
MLA:
Brunner, Maximilian, and Robert Grützmann. "Pancreatic cystic neoplasms Zystische Pankreastumoren." Die Chirurgie (2024).
BibTeX: Download